| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6820055 | Psychosomatics | 2018 | 39 Pages |
Abstract
The evidence for clinically meaningful QT prolongation with most classes of psychiatric agents remains minimal. The most important risk-reducing intervention clinicians can make is undertaking a careful analysis of other QT risk factors when prescribing psychiatric medications.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Scott R. M.D., Christopher M. M.D., Alan M. M.B., B.Ch., Caitlin M.D., Michael J. M.D., Ph.D., Peter A. M.D., Jeff C. M.D.,